Energy metabolism and proliferation in pancreatic carcinogenesis

Langenbeck's Archives of Surgery

Volumn 397, Issue 4, 2012, Pages 507-512

  Regel, Ivonne ^a   Kong, Bo ^a   Raulefs, Susanne ^a   Erkan, Mert ^a   Michalski, Christoph W ^a   Hartel, Mark ^a   Kleeff, Jörg ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Energy metabolism; Pancreatic carcinogenesis; Pancreatic ductal adenocarcinoma (PDAC)

Indexed keywords

GLUCOSE; GLUTAMINE; LACTIC ACID; PROTEIN KINASE LKB1; PYRUVIC ACID;

ACINAR CELL; AMINO ACID METABOLISM; ANAEROBIC GLYCOLYSIS; CANCER DIAGNOSIS; CARCINOGENESIS; CELL PROLIFERATION; DISEASE MODEL; ENERGY METABOLISM; GENE FUNCTION; GENE MUTATION; HUMAN; LKB1 GENE; MALIGNANT TRANSFORMATION; NONHUMAN; ONCOGENE C MYC; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR SUPPRESSOR GENE;

ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DNA MUTATIONAL ANALYSIS; ENERGY METABOLISM; HUMANS; MICE; PANCREATIC NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 84863986550     PISSN: 14352443     EISSN: 14352451     Source Type: Journal    
DOI: 10.1007/s00423-012-0933-9     Document Type: Review

References (62)

1. DeBerardinis RJ et al (2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7 (1):11-20
2. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA: A Cancer Journal for Clinicians 62(1):10-29
3. Aichler M et al (2011) Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues. J Pathol doi: 10.1002/path.3017
4. Vincent A et al (2011) Pancreatic cancer. Lancet 378(9791):607-620
5. Warburg O, Posener K, Negelein E (1924) Über den Stoffwechsel der Tumoren. Biochem Z 152:319-344
6. Hunt TK et al (2007) Aerobically derived lactate stimulates revascularization and tissue repair via redox mechanisms. Antioxid Redox Signal 9(8):1115-1124 (Pubitemid 47080823)
7. Fantin VR, St-Pierre J, Leder P (2006) Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9(6):425-434 (Pubitemid 43832190)
8. Le A et al (2010) Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci USA 107(5):2037-2042
9. Schneiderhan W et al (2009) CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models. Gut 58(10):1391-1398
10. Levine AJ, Puzio-Kuter AM (2010) The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 330(6009):1340-1344
11. Zhou Wet al (2012) Proteomic analysis reveals warburg effect and anomalous metabolism of glutamine in pancreatic cancer cells. J Proteome Res 11(2):554-563
12. Kwon SJ, Lee YJ (2005) Effect of low glutamine/glucose on hypoxia-induced elevation of hypoxia-inducible factor-1alpha in human pancreatic cancer MiaPaCa-2 and human prostatic cancer DU-145 cells. Clin Cancer Res: Off J Am Assoc Cancer Res 11 (13):4694-4700 (Pubitemid 41557187)
13. DeBerardinis RJ et al (2007) Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA 104(49):19345-19350
14. Koppenol WH, Bounds PL, Dang CV (2011) Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 11(5):325-337
15. Frezza C, Pollard PJ, Gottlieb E (2011) Inborn and acquired metabolic defects in cancer. J Mol Med 89(3):213-220
16. Moskaluk CA, Hruban RH, Kern SE (1997) p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res 57(11):2140-2143 (Pubitemid 27247028)
17. Iacobuzio-Donahue CA et al (2009) DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol: Off J Am Soc Clin Oncol 27 (11):1806-1813
18. Hezel AF et al (2006) Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 20(10):1218-1249 (Pubitemid 43727584)
19. Gaglio D et al (2011) Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth. Mol Syst Biol 7:523
20. Yun J et al (2009) Glucose deprivation contributes to the development of KRAS pathwaymutations in tumor cells. Science 325(5947):1555-1559
21. Vizan P et al (2005) K-ras codon-specific mutations produce distinctive metabolic phenotypes in NIH3T3 mice [corrected] fibroblasts. Cancer Res 65(13):5512-5515 (Pubitemid 40911149)
22. Chiaradonna F et al (2006) Ras-dependent carbon metabolism and transformation in mouse fibroblasts. Oncogene 25(39):5391-5404 (Pubitemid 44330282)
23. Skoudy A, Hernandez-Munoz I, Navarro P (2011) Pancreatic ductal adenocarcinoma and transcription factors: role of c-Myc. J Gastrointest Cancer 42(2):76-84
24. Meyer N, Penn LZ (2008) Reflecting on 25 years with MYC. Nat Rev Cancer 8(12):976-990
25. Schleger C et al (2002) c-MYC activation in primary and metastatic ductal adenocarcinoma of the pancreas: incidence, mechanisms, and clinical significance. Mod Pathol 15(4):462-469 (Pubitemid 34326956)
26. Sears R et al (2000) Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev 14(19): 2501-2514
27. Wise DR et al (2008) Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci USA 105(48):18782-18787
28. Dang CV, Le A, Gao P (2009) MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res: Off J Am Assoc Cancer Res 15(21):6479-6483
29. Scarpa A et al (1993) Pancreatic adenocarcinomas frequently show p53 gene mutations. Am J Pathol 142(5):1534-1543 (Pubitemid 24058140)
30. Pellegata NS et al (1994) K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res 54(6):1556-1560 (Pubitemid 24106422)
31. Oren M (2003) Decision making by p53: life, death and cancer. Cell Death Differ 10(4):431-442 (Pubitemid 36626355)
32. Shen L et al (2012) The fundamental role of the p53 pathway in tumor metabolism and its implication in tumor therapy. Clinical Cancer Res (in press)
33. Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E (2004) The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res 64(7):2627-2633 (Pubitemid 38523921)
34. Bensaad K et al (2006) TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126(1):107-120 (Pubitemid 44040989)
35. Mathupala SP, Heese C, Pedersen PL (1997) Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53. J Biol Chem 272(36):22776-22780
36. Hu Wet al (2010) Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc Natl Acad Sci USA 107(16):7455-7460
37. Mehenni H et al (2006) Cancer risks in LKB1 germline mutation carriers. Gut 55(7):984-990 (Pubitemid 43962611)
38. Birnbaum DJ et al (2011) Genome profiling of pancreatic adenocarcinoma. Genes Chromosomes Cancer 50(6):456-465
39. Alessi DR, Sakamoto K, Bayascas JR (2006) LKB1-dependent signaling pathways. Annu Rev Biochem 75:137-163 (Pubitemid 44118029)
40. Katajisto P et al (2007) The LKB1 tumor suppressor kinase in human disease. Biochim Biophys Acta 1775(1):63-75 (Pubitemid 44889272)
41. Sauer B (1987) Functional expression of the cre-lox site-specific recombination system in the yeast Saccharomyces cerevisiae. Mol Cell Biol 7(6):2087-2096
42. Sauer B, Henderson N (1988) Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc Natl Acad Sci USA 85(14):5166-5170
43. Orban PC, Chui D, Marth JD (1992) Tissue-and site-specific DNA recombination in transgenic mice. Proc Natl Acad Sci USA 89 (15):6861-6865
44. Jonsson J et al (1994) Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371(6498):606-609 (Pubitemid 24315741)
45. Offield MF et al (1996) PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122 (3):983-995 (Pubitemid 26096002)
46. Krapp A et al (1998) The bHLH protein PTF1-p48 is essential for the formation of the exocrine and the correct spatial organization of the endocrine pancreas. Genes Dev 12(23):3752-3763 (Pubitemid 29019655)
47. Kawaguchi Y et al (2002) The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. Nat Genet 32(1):128-134 (Pubitemid 34977207)
48. Hingorani SR et al (2005) Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7(5):469-483 (Pubitemid 40719130)
49. Tuveson DA et al (2004) Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell 5(4):375-387 (Pubitemid 38482073)
50. Collins MA et al (2012) Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice. J Clin Invest 122:639-53
51. Jones S et al (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321(5897): 1801-1806
52. Morton JP et al (2010) Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. Proc Natl Acad Sci USA 107(1):246-251
53. Nakada D, Saunders TL, Morrison SJ (2010) Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells. Nature 468(7324):653-658
54. Gurumurthy S et al (2010) The Lkb1 metabolic sensor maintains haematopoietic stem cell survival. Nature 468(7324):659-663
55. Gan B et al (2010) Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells. Nature 468(7324):701-704
56. Sato N et al (2001) STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol 159(6):2017-2022 (Pubitemid 33104257)
57. Hezel AF et al (2008) Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms. Mol Cell Biol 28(7):2414-2425 (Pubitemid 351429985)
58. Morton JP et al (2010) LKB1 haploinsufficiency cooperates with Kras to promote pancreatic cancer through suppression of p21-dependent growth arrest. Gastroenterology 139(2):586-597, 597 e1-6
59. Bonal C et al (2009) Pancreatic inactivation of c-Myc decreases acinar mass and transdifferentiates acinar cells into adipocytes in mice. Gastroenterology 136(1):309-319, e9
60. Nakhai H et al (2008) Conditional inactivation of Myc impairs development of the exocrine pancreas. Development 135(19): 3191-3196
61. Sandgren EP et al (1991) Pancreatic tumor pathogenesis reflects the causative genetic lesion. Proc Natl Acad Sci USA 88(1):93-97 (Pubitemid 21914433)
62. Mazur PK et al (2010) Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma. Proc Natl Acad Sci USA 107(30):13438-13443